Tag: schizophrenia
Feinstein Institutes awarded US$3.4 million to study rTMS therapy in schizophrenia
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening...
Sham-controlled studies indicate effectiveness of TMS for negative schizophrenia symptoms
A systematic review and meta-analysis published in Nature Schizophrenia has concluded that data from sham-controlled studies to date indicate the effectiveness of transcranial magnetic...
Biogen buys Pfizer’s unwanted neuro med for US$75M
Biogen has bought a phase 2-ready schizophrenia drug. They will pay a US$75 million upfront for the therapy, with a follow-up payment of US$515...
